NEW YORK, N.Y., Feb. 17, 2009 (GLOBE NEWSWIRE) -- Tongli Pharmaceuticals (OTCBB:TGLP), a pharmaceutical company specializing in the development, manufacture, and commercialization in the People’s Republic of China of a wide range of prescription and over the counter (“OTC”) pharmaceutical products based on principles of traditional Chinese medicine, today announced financial results for the third quarter ended December 31, 2008.
